362 related articles for article (PubMed ID: 31803695)
1. Targeted Therapies for Pediatric AML: Gaps and Perspective.
Lonetti A; Pession A; Masetti R
Front Pediatr; 2019; 7():463. PubMed ID: 31803695
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199.
Naqvi K; Konopleva M; Ravandi F
Expert Rev Hematol; 2017 Oct; 10(10):863-874. PubMed ID: 28799432
[TBL] [Abstract][Full Text] [Related]
3. Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia.
Sexauer AN; Tasian SK
Front Pediatr; 2017; 5():248. PubMed ID: 29209600
[TBL] [Abstract][Full Text] [Related]
4. Straight to the Point-The Novel Strategies to Cure Pediatric AML.
Lejman M; Dziatkiewicz I; Jurek M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216084
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Relapsed/Refractory Acute Myeloid Leukemia.
Bose P; Vachhani P; Cortes JE
Curr Treat Options Oncol; 2017 Mar; 18(3):17. PubMed ID: 28286924
[TBL] [Abstract][Full Text] [Related]
6. [Acute myeloid leukemia].
Döhner K; Paschka P; Döhner H
Internist (Berl); 2015 Apr; 56(4):354-63. PubMed ID: 25787321
[TBL] [Abstract][Full Text] [Related]
7. Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges.
Ling Y; Zhang Z; Zhang H; Huang Z
Curr Pharm Des; 2017 Nov; 23(29):4303-4310. PubMed ID: 28671056
[TBL] [Abstract][Full Text] [Related]
8. Pediatric acute myeloid leukemia: towards high-quality cure of all patients.
Kaspers GJ; Zwaan CM
Haematologica; 2007 Nov; 92(11):1519-32. PubMed ID: 18024401
[TBL] [Abstract][Full Text] [Related]
9. Pediatric acute myeloid leukemia: Insight into genetic landscape and novel targeted approaches.
Tosic N; Marjanovic I; Lazic J
Biochem Pharmacol; 2023 Sep; 215():115705. PubMed ID: 37532055
[TBL] [Abstract][Full Text] [Related]
10. Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment.
Fleischmann M; Schnetzke U; Schrenk KG; Schmidt V; Sayer HG; Hilgendorf I; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2017 Feb; 143(2):337-345. PubMed ID: 27778197
[TBL] [Abstract][Full Text] [Related]
11. Current Management of Childhood Acute Myeloid Leukemia.
Rubnitz JE
Paediatr Drugs; 2017 Feb; 19(1):1-10. PubMed ID: 27785777
[TBL] [Abstract][Full Text] [Related]
12. New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML).
Chen J; Glasser CL
Children (Basel); 2020 Feb; 7(2):. PubMed ID: 32050659
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
Wiggers CRM; Govers AMAP; Lelieveld D; Egan DA; Zwaan CM; Sonneveld E; Coffer PJ; Bartels M
Pediatr Blood Cancer; 2019 Aug; 66(8):e27785. PubMed ID: 31044544
[TBL] [Abstract][Full Text] [Related]
14. Molecular therapeutic approaches for pediatric acute myeloid leukemia.
Tasian SK; Pollard JA; Aplenc R
Front Oncol; 2014; 4():55. PubMed ID: 24672775
[TBL] [Abstract][Full Text] [Related]
15. Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia.
Obszański P; Kozłowska A; Wańcowiat J; Twardowska J; Lejman M; Zawitkowska J
Molecules; 2022 Jun; 27(12):. PubMed ID: 35745032
[TBL] [Abstract][Full Text] [Related]
16. Current and emerging pharmacotherapy for the treatment of childhood acute myeloid leukemia.
Cuglievan B; McCall D; Robusto L; Mireles ME; Gettys SC
Expert Opin Pharmacother; 2022 Dec; 23(17):1915-1925. PubMed ID: 36346029
[TBL] [Abstract][Full Text] [Related]
17. [Genetic aberrations and new treatment strategies for pediatric acute myeloid leukemia].
Shiba N
Rinsho Ketsueki; 2018; 59(10):2260-2267. PubMed ID: 30305534
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of
Lonetti A; Indio V; Laginestra MA; Tarantino G; Chiarini F; Astolfi A; Bertuccio SN; Martelli AM; Locatelli F; Pession A; Masetti R
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32698374
[TBL] [Abstract][Full Text] [Related]
19. Novel treatments for relapsed/refractory acute myeloid leukemia with
Tallis E; Borthakur G
Expert Rev Hematol; 2019 Aug; 12(8):621-640. PubMed ID: 31232619
[No Abstract] [Full Text] [Related]
20. Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia.
Shallis RM; Bewersdorf JP; Boddu PC; Zeidan AM
Expert Rev Anticancer Ther; 2019 Aug; 19(8):717-729. PubMed ID: 31422721
[No Abstract] [Full Text] [Related]
[Next] [New Search]